rutin has been researched along with Hemolysis* in 3 studies
3 other study(ies) available for rutin and Hemolysis
Article | Year |
---|---|
In vitro anticomplementary activity of constituents from Morinda morindoides.
In a screening program for complement classical pathway modulation, an 80% MeOH extract of the leaves of Morinda morindoides showed potent dose-dependent anticomplementary activity. Bioassay-guided chromatographic separation of the active constituents led to the isolation of ten flavonoids of which two were aglycones. The compounds were tested in vitro for their putative complement-inhibiting properties on the classical (CP) and the alternative (AP) pathways of the complement system. The results indicated that quercetin [1], quercetin 3-O-rhamnoside (quercitrin) [5], and quercetin 3-O-rutinoside (rutin) [7] showed similar anticomplementary activities (inhibition) on the CP of complement. A mixture of two kaempferol triglycosides isolated and denoted as M(015), also had a good inhibitory effect. The effects of these compounds were dose-dependent for this pathway. On the AP of complement, quercetin [1] and M(015) had, respectively, more pronounced inhibitory and activatory effects than the other tested flavonoids, but their effects were not dose-dependent for this pathway. The other isolated flavonoids showed weak effects or were inactive for both pathways. Topics: Animals; Complement Inactivator Proteins; Complement Pathway, Alternative; Complement Pathway, Classical; Flavonoids; Guinea Pigs; Hemolysis; Humans; In Vitro Techniques; Plant Extracts; Plant Leaves; Plants, Medicinal; Rabbits; Sheep | 1995 |
[IE and IgG antibodies against flavonoids following therapy with flavonoid-containing drugs].
During treatment with flavonoid drugs a number of patients developed adverse reactions such as fever, various skin eruptions and intravascular hemolysis. The appearance of flavonoid-specific IgE and IgG antibodies and its possible relation to the observed side effects was studied on a total of 168 individuals treated with flavonoid drugs: 71 patients received troxerutin (Venoruton) parenterally to improve tolerance of radiation therapy, 12 patients were treated intravenously with silymarin (Legalon) for amanita intoxication and 77 patients received various flavonoid drugs for other indications. Flavonoid treatment often induced specific IgG antibodies and less frequently IgE antibodies. After short treatment IgE antibodies were more frequently detected than after treatment of longer duration which nearly always induced IgG antibodies. Patients with hemolysis had the highest IgG titers. In cases with fever and skin eruptions no correlation with antibody titers became evident. Antibody production in patients undergoing radiation therapy appeared to be lower than in non-irradiated patients. Both the IgE and IgG antibody test show a remarkable cross-reactivity between four different flavonoids. Prospective studies will be necessary to decide whether or not this method for the detection of anti-flavonoid antibodies will be suitable for recognizing increased risk of side reactions upon reexposure to flavonoid drugs. Topics: Catechin; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; Fever; Flavonoids; Hemolysis; Humans; Hydroxyethylrutoside; Immunoglobulin E; Immunoglobulin G; Male; Radiation-Protective Agents; Radioallergosorbent Test; Silymarin | 1986 |
Studies on the haemolytic action of amphiphilic substances in vitro. Inhibition by O-(beta-hydroxyethyl)-rutosides.
Topics: Chemical Phenomena; Chemistry, Physical; Depression, Chemical; Escin; Hemolysis; Humans; Hydroxyethylrutoside; In Vitro Techniques; Rutin | 1981 |